Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Market Drivers
     3.1 Public and Private Expenditure on Healthcare
     3.2 Rising Number of Clinical Trials
     3.3 Rising Disposable Income
     3.4 Ageing Population

4. Market Challenges
     4.1 High Prices of Medications
     4.2 Dependence on Imported Drugs
     4.3 Stringent Drug Licensing and Regulatory Laws
     4.4 High Tax Burden

5. Pharmaceutical Industry Overview

6. Market Segmentation
     6.1 OTC Drug
            6.1.1 Regulatory Framework
     6.2 Generics
            6.2.1 Regulatory Framework
     6.3 Prescription Drug
            6.3.1 Regulatory Framework

7. Therapeutic Segments in Brazil
     7.1 Oncology
     7.2 Infectious Diseases
     7.3 Cardiovascular and Diabetes
     7.4 CNS Diseases

8. Mergers and Acquisitions (Premium Deals since 2010)

9. Competitive Landscape
     9.1 Share of Domestic Vs International Players
     9.2 Overall Market Share Breakdown

10. Key Players
     10.1 EMS
     10.2 Hypermarcas
     10.3 Ache Laboratories
     10.4 Eurofarma
     10.5 Sanofi-Aventis
     10.6 F. Hoffmann La Roche
     10.7 Novartis
     10.8 Pfizer
     10.9 Merck Group